Open Access
Current advances in using neurotrophic factors to treat neurodegenerative disorders
Publication type: Journal Article
Publication date: 2012-07-26
scimago Q1
wos Q1
SJR: 3.850
CiteScore: 18.9
Impact factor: 15.2
ISSN: 20479158
PubMed ID:
23210531
Cellular and Molecular Neuroscience
Cognitive Neuroscience
Neurology (clinical)
Abstract
Neurotrophic factors are best known for their roles in both development and continued maintenance of the nervous system. Their strong potential to elicit pro-survival and pro-functional responses in neurons of the peripheral and central nervous system make them good drug candidates for treatment of a multitude of neurodegenerative disorders. However, significant obstacles remain and need to be overcome before translating the potential of neurotrophins into the therapeutic arena. This article addresses current efforts and advances in resolving these challenges and provides an overview of roadmaps for future translational research and neurotrophin-based drug developments.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
International Journal of Molecular Sciences
6 publications, 3.57%
|
|
|
Molecular Neurobiology
5 publications, 2.98%
|
|
|
Scientific Reports
5 publications, 2.98%
|
|
|
Frontiers in Neuroscience
4 publications, 2.38%
|
|
|
Frontiers in Molecular Neuroscience
3 publications, 1.79%
|
|
|
Neuropharmacology
3 publications, 1.79%
|
|
|
Nutritional Neuroscience
3 publications, 1.79%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
2 publications, 1.19%
|
|
|
Molecular Medicine Reports
2 publications, 1.19%
|
|
|
Frontiers in Pharmacology
2 publications, 1.19%
|
|
|
Journal of Applied Phycology
2 publications, 1.19%
|
|
|
Cellular and Molecular Life Sciences
2 publications, 1.19%
|
|
|
Translational Neurodegeneration
2 publications, 1.19%
|
|
|
Neuroscience Research
2 publications, 1.19%
|
|
|
Advanced Drug Delivery Reviews
2 publications, 1.19%
|
|
|
Medicinal Research Reviews
2 publications, 1.19%
|
|
|
PLoS ONE
2 publications, 1.19%
|
|
|
Neurobiology of Disease
2 publications, 1.19%
|
|
|
Molecular and Cellular Neurosciences
2 publications, 1.19%
|
|
|
ACS Chemical Neuroscience
2 publications, 1.19%
|
|
|
Reviews in the Neurosciences
2 publications, 1.19%
|
|
|
Evidence-based Complementary and Alternative Medicine
2 publications, 1.19%
|
|
|
Current Neuropharmacology
2 publications, 1.19%
|
|
|
Neurochemical Research
2 publications, 1.19%
|
|
|
CNS Drugs
1 publication, 0.6%
|
|
|
Nanomedicine
1 publication, 0.6%
|
|
|
Journal of Huntington's disease
1 publication, 0.6%
|
|
|
Stem Cells and Development
1 publication, 0.6%
|
|
|
NeuroReport
1 publication, 0.6%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Springer Nature
42 publications, 25%
|
|
|
Elsevier
37 publications, 22.02%
|
|
|
Frontiers Media S.A.
13 publications, 7.74%
|
|
|
MDPI
12 publications, 7.14%
|
|
|
Wiley
11 publications, 6.55%
|
|
|
Taylor & Francis
9 publications, 5.36%
|
|
|
American Chemical Society (ACS)
6 publications, 3.57%
|
|
|
Bentham Science Publishers Ltd.
5 publications, 2.98%
|
|
|
Hindawi Limited
4 publications, 2.38%
|
|
|
Spandidos Publications
2 publications, 1.19%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.19%
|
|
|
Walter de Gruyter
2 publications, 1.19%
|
|
|
IntechOpen
2 publications, 1.19%
|
|
|
IOS Press
1 publication, 0.6%
|
|
|
Mary Ann Liebert
1 publication, 0.6%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.6%
|
|
|
SAGE
1 publication, 0.6%
|
|
|
Aging and Disease
1 publication, 0.6%
|
|
|
European Molecular Biology Organization
1 publication, 0.6%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.6%
|
|
|
Rockefeller University Press
1 publication, 0.6%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.6%
|
|
|
AME Publishing Company
1 publication, 0.6%
|
|
|
Society for Neuroscience
1 publication, 0.6%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.6%
|
|
|
Media Sphere Publishing House
1 publication, 0.6%
|
|
|
Centro de Estudos de Venenos e Animais Peconhentos
1 publication, 0.6%
|
|
|
Innovare Academic Sciences
1 publication, 0.6%
|
|
|
Korean Society for Brain and Neural Science
1 publication, 0.6%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
168
Total citations:
168
Citations from 2025:
11
(6.55%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Weissmiller A. M., Wu C. Current advances in using neurotrophic factors to treat neurodegenerative disorders // Translational Neurodegeneration. 2012. Vol. 1. No. 1. 14
GOST all authors (up to 50)
Copy
Weissmiller A. M., Wu C. Current advances in using neurotrophic factors to treat neurodegenerative disorders // Translational Neurodegeneration. 2012. Vol. 1. No. 1. 14
Cite this
RIS
Copy
TY - JOUR
DO - 10.1186/2047-9158-1-14
UR - https://doi.org/10.1186/2047-9158-1-14
TI - Current advances in using neurotrophic factors to treat neurodegenerative disorders
T2 - Translational Neurodegeneration
AU - Weissmiller, April M
AU - Wu, Chengbiao
PY - 2012
DA - 2012/07/26
PB - Springer Nature
IS - 1
VL - 1
PMID - 23210531
SN - 2047-9158
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2012_Weissmiller,
author = {April M Weissmiller and Chengbiao Wu},
title = {Current advances in using neurotrophic factors to treat neurodegenerative disorders},
journal = {Translational Neurodegeneration},
year = {2012},
volume = {1},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1186/2047-9158-1-14},
number = {1},
pages = {14},
doi = {10.1186/2047-9158-1-14}
}